Pregnancy in long QT syndrome with implantable cardioverter-defibrillator. A case report and review of the literature
References
- [1] Pavia S, Wilkoff B. The management of surgical complications of pacemaker and implantable cardioverterdefibrillators. Curr Opin Cardiol 2001;16:66-71.
- [2] Schuler PK, Herrey A, Wade A, Brooks R, Peebles D, Lambiase P, Walker F. Pregnancy outcome and management of women with an implantable cardioverter defibrillator: a single centre experience. Europace 2012;14:1740-5.
- [3] Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 2008;51:1685-91.
- [4] Natale A, Davidson T, Geiger MJ, Newby K. Implantable cardioverter-defibrillators and pregnancy. A safe combination? Circulation 1997;96:2808-12.
- [5] Silversides CK, Harris L, Haberer K, Sermer M, Colman JM, Siu SC. Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. Am J Cardiol 2006;97:1206-12.
- [6] Bonin W, Botto GL, Broffoni T, Dondina C. Pregnancy with an ICD and a documented ICD discharge. Europace 2000;2:87-90.
- [7] Natale A, Davidson T, Geiger MJ, Newby K. Implantable cardioverter-defibrillators and pregnancy. A safe combination? Circulation 1997;96:2808-12.
- [8] Page RL. Treatment of arrhythmias during pregnancy. Am Heart J 1995;130:871-6.
- [9] Cordina R, McGuire MA. Maternal cardiac arrhythmias during pregnancy and lactation. Obstet Med 2010;3:8-16.
- [10] Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J 2011;32:3147-97.
- [11] Martilloti G, Talajic M, Rey E, Leduc L. Long QT syndrome in pregnancy: are vaginal delivery and use of oxytocin permitted? A case report. J Obstet Gynaecol Can 2012;34:1073-6.
- [12] Kukla P, Filipecki A, Jastrzebski M, Plato A, Kukla M, Malarczyk-Zaher B, et al. Long QT syndrome in the postpartum period. Kardiol Pol 2009;67:795-9.
- [13] Giudicessi JR, Brost BC, Traynor KD, Ackerman MJ. Potential depot medroxyprogesterone acetate-triggered torsades de pointes in a case of congenital type 2 long QT syndrome. Heart Rhythm 2012;9:1143-7.
- [14] Joglar JA, Page RL. Antiarrhythmic drugs in pregnancy. Curr Opin Cardiol 2001;16:40-5.
- [15] Seth R, Moss AJ, McNitt S, Zareba W, Andrews ML, Qi M, et al. Long QT syndrome and pregnancy. J Am Coll Cardiol 2007;49:1092-8.
- [16] Gowd BM, Thompson PD. Effect of female sex on cardiac arrhythmias. Heart Rhythm 2012;9:1148-9.
- [17] Curtis AB, Narasimha D. Arrhythmias in women. Clin Cardiol 2012;35:166-71.
- [18] Isaacs JD, Mulholland DH, Hess LW, Allbert JR, Martin RW. Pregnancy in woman with an automatic implantable cardioverter-defibrillator. A case report. J Reproductive Med 1993;38:487-8.
- [19] Yost S, McDonald B, Vallejo M. Anesthetic management of a pregnant patient with an automatic implantable cardioverter-defibrillator: a case report. AANA Journal 2009;77:29-32.
- [20] Su TS, Kang HS, Forrest C. Implantable cardioverter defibrillators and long QT syndrome in pregnancy: a case report. Anesthesiology 2006;105:A1668.
- [21] Nakamura H, Kurokawa J, Bai CX. Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study. Circulation 2007;116:2913-22. 4
DOI: https://doi.org/10.2478/semcard-2014-0001 | Journal eISSN: 1822-7767
Language: English
Page range: 1 - 4
Submitted on: Dec 16, 2013
Accepted on: Feb 24, 2014
Published on: May 30, 2014
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Related subjects:
© 2014 Sandra Kutkiene˙, Lina Gumbiene, Juratę Aganauskiene, Rima Steponenienea, Germanas Marinskisa, Audrius Aidietis, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.